Pencegahan Kanker Sofia Peterson ” NOWAK, BOSTON, CANCER PREVENTION, CELEBREX, CLINICAL TRIALS, COVID-19, DANA - FARBER CANCER, DANA - FARBER CANCER INSTITUTE, DISEASE PREVENTION, HALE FAMILY, HARVARD MEDICAL SCHOOL, HPV VACCINE, JONATHAN NOWAK, MASSACHUSETTS, MEDICAL SCHOOL, MEDICINE, NORTH AMERICA, UNITED STATES Status ctDNA Prediksi Manfaat DFS Celecoxib pada Kanker Kolorektal Stadium III
Pencegahan Kanker Sofia Peterson ” NOWAK, BOSTON, CANCER PREVENTION, CELEBREX, CLINICAL TRIALS, COVID-19, DANA - FARBER CANCER, DANA - FARBER CANCER INSTITUTE, DISEASE PREVENTION, HALE FAMILY, HARVARD MEDICAL SCHOOL, HPV VACCINE, JONATHAN NOWAK, MASSACHUSETTS, MEDICAL SCHOOL, MEDICINE, NORTH AMERICA, UNITED STATES Status ctDNA Memprediksi Manfaat DFS dari Celecoxib pada Kanker Usus Besar Stadium III
Pencegahan Kanker Penelitian Aiden Caldwell ” NOWAK, BOSTON, CANCER INSTITUTE, CANCER PREVENTION, CENTER FOR, CLINICAL TRIALS, COVID-19, DANA - FARBER, DANA - FARBER CANCER INSTITUTE, HALE FAMILY CENTER FOR PANCREATIC CANCER RESEARCH, HARVARD MEDICAL SCHOOL, HPV VACCINE, JONATHAN NOWAK, MASSACHUSETTS, MEDICINE, NORTH AMERICA, NOWAK, RESEARCH, UNITED STATES Status ctDNA Prognostik untuk DFS dengan Celecoxib pada Kanker Kolon Stadium III
